Barnes Alane P bought BCRX
March 16, 2026 · Form 4 insider transaction
Barnes Alane P bought 150,000 shares of BioCryst Pharmaceuticals, Inc. at $5.51 per share, a transaction worth $826.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
150,000
Price
$5.51
Total value
$826.5K
InsiderBarnes Alane P
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 16, 2026
Filing dateMarch 18, 2026
Shares owned after550,703
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.